Therapeutic antibodies for improved wound healing.
Therapeutic monoclonal antibodies (mAbs) are the fastest growing area of drug development, with an increasing number of diseases, including rheumatoid arthritis, multiple sclerosis and various forms of cancer, now amenable to treatment. Therapeutic mAbs bind to proteins or cells that are involved in...
| Publicado en: | Wound Practice & Research Vol. 23; no. 1; pp. 16 - 25 |
|---|---|
| Autores principales: | , , |
| Formato: | pictorial review Journal Article |
| Publicado: |
Cambridge Publishing
Mar2015
|
| Acceso en línea: | Ver este registro en EBSCOhost |